{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:01:35Z","timestamp":1791295295527,"version":"4.1.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T00:00:00Z","timestamp":1449705600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","award":["25253047"],"award-info":[{"award-number":["25253047"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology of Japan","doi-asserted-by":"crossref","award":["15K19243"],"award-info":[{"award-number":["15K19243"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare (JP)","doi-asserted-by":"publisher","award":["H26-Nanjito-Ippan-078"],"award-info":[{"award-number":["H26-Nanjito-Ippan-078"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Environ Health Prev Med"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12199-015-0498-7","type":"journal-article","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T04:40:30Z","timestamp":1449981630000},"page":"55-70","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["A new horizon of moyamoya disease and associated health risks explored through RNF213"],"prefix":"10.1007","volume":"21","author":[{"given":"Akio","family":"Koizumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatasu","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Hitomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji H.","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Habu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohab","family":"Youssefian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,10]]},"reference":[{"key":"498_CR1","first-page":"85","volume":"14","author":"Y Hosoda","year":"1976","unstructured":"Hosoda Y. A pathological study of so-called \u201cspontaneous occulusion of the circle of Willis\u201d (\u201ccerebrovascular moyamoya disease\u201d). Folia Angiol. 1976;14:85\u20136.","journal-title":"Folia Angiol"},{"key":"498_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF02155663","volume":"392","author":"K Oka","year":"1981","unstructured":"Oka K, Yamashita M, Sadoshima S, Tanaka K. Cerebral haemorrhage in moyamoya disease at autopsy. Virchows Arch A Pathol Anat Histol. 1981;392:247\u201361.","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"498_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular, \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288\u201399.","journal-title":"Arch Neurol"},{"key":"498_CR4","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.108.806307","volume":"119","author":"C Amlie-Lefond","year":"2009","unstructured":"Amlie-Lefond C, Bernard TJ, Sebire G, Friedman NR, Heyer GL, Lerner NB, et al. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation. 2009;119:1417\u201323. doi: 10.1161\/CIRCULATIONAHA.108.806307 .","journal-title":"Circulation"},{"key":"498_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1542\/peds.109.1.116","volume":"109","author":"JK Lynch","year":"2002","unstructured":"Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics. 2002;109:116\u201323. doi: 10.1542\/peds.109.1.116 .","journal-title":"Pediatrics"},{"key":"498_CR6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/2011.6.PEDS10578","volume":"8","author":"JH Phi","year":"2011","unstructured":"Phi JH, Wang KC, Cho BK, Lee MS, Lee JH, Yu KS, et al. Long-term social outcome in children with moyamoya disease who have reached adulthood. J Neurosurg Pediatr. 2011;8:303\u20139. doi: 10.3171\/2011.6.PEDS10578 .","journal-title":"J Neurosurg Pediatr"},{"key":"498_CR7","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3340\/jkns.2015.57.6.390","volume":"57","author":"T Kim","year":"2015","unstructured":"Kim T, Lee H, Bang JS, Kwon OK, Hwang G, Oh CW. Epidemiology of moyamoya disease in Korea: based on national health insurance service data. J Korean Neurosurg Soc. 2015;57:390\u20135. doi: 10.3340\/jkns.2015.57.6.390 .","journal-title":"J Korean Neurosurg Soc"},{"key":"498_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056\u201366. doi: 10.1016\/S1474-4422(08)70240-0 .","journal-title":"Lancet Neurol"},{"key":"498_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/TACG.S42772","volume":"8","author":"S Guey","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49\u201368. doi: 10.2147\/TACG.S42772 .","journal-title":"Appl Clin Genet"},{"key":"498_CR10","unstructured":"Koizumi A. Genetic analysis of familial moyamoya. In: Annual report (2010) of the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease by Science Research Grants of Ministry of Health, Labor and Welfare, Japan (Chaired by N. Hashimoto) 2010. p. 25\u201326."},{"key":"498_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet. 2011;56:34\u201340. doi: 10.1038\/jhg.2010.132 .","journal-title":"J Hum Genet"},{"key":"498_CR12","doi-asserted-by":"publisher","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6:e22542. doi: 10.1371\/journal.pone.0022542 .","journal-title":"PLoS ONE"},{"key":"498_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. Homozygous c.14576G\u00a0>\u00a0A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78:803\u201310. doi: 10.1212\/WNL.0b013e318249f71f .","journal-title":"Neurology"},{"key":"498_CR14","doi-asserted-by":"publisher","first-page":"e48179","DOI":"10.1371\/journal.pone.0048179","volume":"7","author":"Z Wu","year":"2012","unstructured":"Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS ONE. 2012;7:e48179. doi: 10.1371\/journal.pone.0048179 .","journal-title":"PLoS ONE"},{"key":"498_CR15","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","volume":"45","author":"AC Cecchi","year":"2014","unstructured":"Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RL, Leal SM, et al. RNF213 rare variants in an ethnically diverse population with moyamoya disease. Stroke. 2014;45:3200\u20137. doi: 10.1161\/STROKEAHA.114.006244 .","journal-title":"Stroke"},{"key":"498_CR16","doi-asserted-by":"publisher","first-page":"e0130663","DOI":"10.1371\/journal.pone.0130663","volume":"10","author":"OY Bang","year":"2015","unstructured":"Bang OY, Ryoo S, Kim SJ, Yoon CH, Cha J, Yeon JY, et al. Adult moyamoya disease: a burden of intracranial stenosis in east asians? PLoS ONE. 2015;10:e0130663. doi: 10.1371\/journal.pone.0130663 .","journal-title":"PLoS ONE"},{"key":"498_CR17","doi-asserted-by":"publisher","first-page":"e001862","DOI":"10.1161\/JAHA.115.001862","volume":"4","author":"Y Moteki","year":"2015","unstructured":"Moteki Y, Onda H, Kasuya H, Yoneyama T, Okada Y, Hirota K, et al. Systematic validation of RNF213 coding variants in Japanese Patients With Moyamoya Disease. J Am Heart Assoc. 2015;4:e001862. doi: 10.1161\/JAHA.115.001862 .","journal-title":"J Am Heart Assoc"},{"key":"498_CR18","doi-asserted-by":"publisher","unstructured":"Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo) 2012;52:299\u2013303. doi: 10.2176\/nmc.52.299 .","DOI":"10.2176\/nmc.52.299"},{"key":"498_CR19","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1038\/srep04442","volume":"4","author":"D Morito","year":"2014","unstructured":"Morito D, Nishikawa K, Hoseki J, Kitamura A, Kotani Y, Kiso K, et al. Moyamoya disease-associated protein mysterin\/RNF213 is a novel AAA+ ATPase, which dynamically changes its oligomeric state. Sci Rep. 2014;4:4442. doi: 10.1038\/srep04442 .","journal-title":"Sci Rep"},{"key":"498_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bbrc.2013.02.015","volume":"432","author":"H Kobayashi","year":"2013","unstructured":"Kobayashi H, Yamazaki S, Takashima S, Liu W, Okuda H, Yan J, et al. Ablation of Rnf213 retards progression of diabetes in the Akita mouse. Biochem Biophys Res Commun. 2013;432:519\u201325. doi: 10.1016\/j.bbrc.2013.02.015 .","journal-title":"Biochem Biophys Res Commun"},{"key":"498_CR21","doi-asserted-by":"publisher","first-page":"e002146","DOI":"10.1161\/JAHA.115.002496","volume":"4","author":"H Kobayashi","year":"2015","unstructured":"Kobayashi H, Matsuda Y, Hitomi T, Okuda H, Shioi H, Matsuda T, et al. Biochemical and functional characterization of RNF213 (mysterin) R4810K, a susceptibility mutation of moyamoya disease, in angiogenesis in vitro and in vivo. J Am Heart Assoc. 2015;4:e002146. doi: 10.1161\/JAHA.115.002146 .","journal-title":"J Am Heart Assoc"},{"key":"498_CR22","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1097\/WNR.0000000000000289","volume":"25","author":"S Sonobe","year":"2014","unstructured":"Sonobe S, Fujimura M, Niizuma K, Fujimura T, Furudate S, Nishijima Y, et al. Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene. NeuroReport. 2014;25:1442\u20136. doi: 10.1097\/WNR.0000000000000289 .","journal-title":"NeuroReport"},{"key":"498_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.brainres.2014.11.014","volume":"1594","author":"A Ito","year":"2015","unstructured":"Ito A, Fujimura M, Niizuma K, Kanoke A, Sakata H, Morita-Fujimura Y, et al. Enhanced post-ischemic angiogenesis in mice lacking RNF213; a susceptibility gene for moyamoya disease. Brain Res. 2015;1594:310\u201320. doi: 10.1016\/j.brainres.2014.11.014 .","journal-title":"Brain Res"},{"key":"498_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","volume":"438","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, et al. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G\u00a0>\u00a0A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients. Biochem Biophys Res Commun. 2013;438:13\u20139. doi: 10.1016\/j.bbrc.2013.07.004 .","journal-title":"Biochem Biophys Res Commun"},{"key":"498_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1161\/01.STR.14.1.50","volume":"14","author":"M Yamashita","year":"1983","unstructured":"Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke. 1983;14:50\u20138. doi: 10.1161\/01.STR.14.1.50 .","journal-title":"Stroke"},{"key":"498_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1161\/01.STR.15.2.264","volume":"15","author":"M Yamashita","year":"1984","unstructured":"Yamashita M, Oka K, Tanaka K. Cervico-cephalic arterial thrombi and thromboemboli in moyamoya disease\u2013possible correlation with progressive intimal thickening in the intracranial major arteries. Stroke. 1984;15:264\u201370. doi: 10.1161\/01.STR.15.2.264 .","journal-title":"Stroke"},{"key":"498_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1212\/WNL.18.5.485","volume":"18","author":"T Kudo","year":"1968","unstructured":"Kudo T. Spontaneous occlusion of the circle of Willis. A disease apparently confined to Japanese. Neurology. 1968;18:485\u201396.","journal-title":"Neurology"},{"key":"498_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3171\/jns.1968.29.3.0255","volume":"29","author":"A Nishimoto","year":"1968","unstructured":"Nishimoto A, Takeuchi S. Abnormal cerebrovascular network related to the internal cartoid arteries. J Neurosurg. 1968;29:255\u201360. doi: 10.3171\/jns.1968.29.3.0255 .","journal-title":"J Neurosurg"},{"key":"498_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2176\/nmc.52.245","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis","year":"2012","unstructured":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir. 2012;52:245\u2013266.","journal-title":"Neurol Med Chir"},{"key":"498_CR30","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1161\/STROKEAHA.113.002477","volume":"44","author":"S Miyawaki","year":"2013","unstructured":"Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Mukasa A, et al. Genetic variant RNF213 c.14576G\u00a0>\u00a0A in various phenotypes of intracranial major artery stenosis\/occlusion. Stroke. 2013;44:2894\u20137. doi: 10.1161\/STROKEAHA.113.002477 .","journal-title":"Stroke"},{"key":"498_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1086\/302243","volume":"64","author":"H Ikeda","year":"1999","unstructured":"Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533\u20137. doi: 10.1086\/302243 .","journal-title":"Am J Hum Genet"},{"key":"498_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/088307380001500307","volume":"15","author":"TK Inoue","year":"2000","unstructured":"Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000;15:179\u201382. doi: 10.1177\/088307380001500307 .","journal-title":"J Child Neurol"},{"key":"498_CR33","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s10038-004-0143-6","volume":"49","author":"K Sakurai","year":"2004","unstructured":"Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, Fukui M, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004;49:278\u201381. doi: 10.1007\/s10038-004-0143-6 .","journal-title":"J Hum Genet"},{"key":"498_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/01.STR.31.4.930","volume":"31","author":"T Yamauchi","year":"2000","unstructured":"Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930\u20135. doi: 10.1161\/01.STR.31.4.930 .","journal-title":"Stroke"},{"key":"498_CR35","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1212\/01.wnl.0000291012.49986.f9","volume":"70","author":"Y Mineharu","year":"2008","unstructured":"Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008;70:2357\u201363. doi: 10.1212\/01.wnl.0000291012.49986.f9 .","journal-title":"Neurology"},{"key":"498_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s12199-009-0116-7","volume":"15","author":"W Liu","year":"2010","unstructured":"Liu W, Hashikata H, Inoue K, Matsuura N, Mineharu Y, Kobayashi H, et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med. 2010;15:94\u2013104. doi: 10.1007\/s12199-009-0116-7 .","journal-title":"Environ Health Prev Med"},{"key":"498_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jns.2015.04.019","volume":"353","author":"MJ Lee","year":"2015","unstructured":"Lee MJ, Chen YF, Fan PC, Wang KC, Wang K, Wang J, et al. Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan. J Neurol Sci. 2015;353:161\u20135. doi: 10.1016\/j.jns.2015.04.019 .","journal-title":"J Neurol Sci"},{"key":"498_CR38","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226\u201337. doi: 10.1056\/NEJMra0804622 .","journal-title":"N Engl J Med"},{"key":"498_CR39","doi-asserted-by":"publisher","unstructured":"Harel T, Posey JE, Graham BH, Walkiewicz M, Yang Y, Lalani SR, et al. Atypical presentation of moyamoya disease in an infant with a de novo RNF213 variant. Am J Med Genet A (online:2015.7.21), doi: 10.1002\/ajmg.a.37230 .","DOI":"10.1002\/ajmg.a.37230"},{"key":"498_CR40","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/jhg.2012.105","volume":"57","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Touho H, Miyake N, Ohba C, Doi H, Saitsu H, et al. Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G\u00a0>\u00a0A variant in RNF213 showed varying clinical course and severity. J Hum Genet. 2012;57:804\u20136. doi: 10.1038\/jhg.2012.105 .","journal-title":"J Hum Genet"},{"key":"498_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s12199-012-0299-1","volume":"18","author":"A Koizumi","year":"2013","unstructured":"Koizumi A, Kobayashi H, Liu W, Fujii Y, Senevirathna ST, Nanayakkara S, et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med. 2013;18:121\u20139. doi: 10.1007\/s12199-012-0299-1 .","journal-title":"Environ Health Prev Med"},{"key":"498_CR42","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/j.1365-2443.2001.00447.x","volume":"6","author":"T Ogura","year":"2001","unstructured":"Ogura T, Wilkinson AJ. AAA+ superfamily ATPases: common structure\u2013diverse function. Genes Cells. 2001;6:575\u201397. doi: 10.1046\/j.1365-2443.2001.00447.x .","journal-title":"Genes Cells"},{"key":"498_CR43","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1073\/pnas.95.15.8630","volume":"95","author":"BV Geisbrecht","year":"1998","unstructured":"Geisbrecht BV, Collins CS, Reuber BE, Gould SJ. Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. Proc Natl Acad Sci USA. 1998;95:8630\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"498_CR44","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ng1297-445","volume":"17","author":"BE Reuber","year":"1997","unstructured":"Reuber BE, Germain-Lee E, Collins CS, Morrell JC, Ameritunga R, Moser HW, et al. Mutations in PEX1 are the most common cause of peroxisome biogenesis disorders. Nat Genet. 1997;17:445\u20138. doi: 10.1038\/ng1297-445 .","journal-title":"Nat Genet"},{"key":"498_CR45","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2010.11.036","volume":"68","author":"JO Johnson","year":"2010","unstructured":"Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857\u201364. doi: 10.1016\/j.neuron.2010.11.036 .","journal-title":"Neuron"},{"key":"498_CR46","doi-asserted-by":"publisher","unstructured":"Abramzon Y, Johnson JO, Scholz SW, Taylor JP, Brunetti M, Calvo A, et al. Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2012;33:2231 e2231\u20132231 e2236. doi: 10.1016\/j.neurobiolaging.2012.04.005 .","DOI":"10.1016\/j.neurobiolaging.2012.04.005"},{"key":"498_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3171\/jns.1991.75.2.0267","volume":"75","author":"M Hoshimaru","year":"1991","unstructured":"Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg. 1991;75:267\u201370. doi: 10.3171\/jns.1991.75.2.0267 .","journal-title":"J Neurosurg"},{"key":"498_CR48","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3171\/jns.1998.89.4.0623","volume":"89","author":"M Hojo","year":"1998","unstructured":"Hojo M, Hoshimaru M, Miyamoto S, Taki W, Nagata I, Asahi M, et al. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg. 1998;89:623\u20139. doi: 10.3171\/jns.1998.89.4.0623 .","journal-title":"J Neurosurg"},{"key":"498_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jcp.1041470202","volume":"147","author":"M Aoyagi","year":"1991","unstructured":"Aoyagi M, Fukai N, Sakamoto H, Shinkai T, Matsushima Y, Yamamoto M, et al. Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease. J Cell Physiol. 1991;147:191\u20138. doi: 10.1002\/jcp.1041470202 .","journal-title":"J Cell Physiol"},{"key":"498_CR50","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1161\/01.STR.0000148237.13659.e6","volume":"35","author":"R Nanba","year":"2004","unstructured":"Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke. 2004;35:2837\u201342. doi: 10.1161\/01.STR.0000148237.13659.e6 .","journal-title":"Stroke"},{"key":"498_CR51","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.07.028","volume":"24","author":"M Maruwaka","year":"2015","unstructured":"Maruwaka M, Yoshikawa K, Okamoto S, Araki Y, Sumitomo M, Kawamura A, et al. Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption\/ionization time-of-flight mass spectrometry. J Stroke Cerebrovasc Dis. 2015;24:104\u201311. doi: 10.1016\/j.jstrokecerebrovasdis.2014.07.028 .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"498_CR52","doi-asserted-by":"publisher","first-page":"13191","DOI":"10.1038\/srep13191","volume":"5","author":"K Ohkubo","year":"2015","unstructured":"Ohkubo K, Sakai Y, Inoue H, Akamine S, Ishizaki Y, Matsushita Y, et al. Moyamoya disease susceptibility gene RNF213 links inflammatory and angiogenic signals in endothelial cells. Sci Rep. 2015;5:13191. doi: 10.1038\/srep13191 .","journal-title":"Sci Rep"},{"key":"498_CR53","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/jnr.22228","volume":"88","author":"JH Kim","year":"2010","unstructured":"Kim JH, Jung JH, Phi JH, Kang HS, Kim JE, Chae JH, et al. Decreased level and defective function of circulating endothelial progenitor cells in children with moyamoya disease. J Neurosci Res. 2010;88:510\u20138. doi: 10.1002\/jnr.22228 .","journal-title":"J Neurosci Res"},{"key":"498_CR54","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/carcin\/bgl231","volume":"28","author":"CS Kim","year":"2007","unstructured":"Kim CS, Ying H, Willingham MC, Cheng SY. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer. Carcinogenesis. 2007;28:932\u20139. doi: 10.1093\/carcin\/bgl231 .","journal-title":"Carcinogenesis"},{"key":"498_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10456-009-9146-4","volume":"12","author":"I Arnaoutova","year":"2009","unstructured":"Arnaoutova I, George J, Kleinman HK, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis. 2009;12:267\u201374. doi: 10.1007\/s10456-009-9146-4 .","journal-title":"Angiogenesis"},{"key":"498_CR56","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2013.08.067","volume":"439","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H, Okuda H, Harada KH, Osafune K, et al. The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality. Biochem Biophys Res Commun. 2013;439:419\u201326. doi: 10.1016\/j.bbrc.2013.08.067 .","journal-title":"Biochem Biophys Res Commun"},{"key":"498_CR57","doi-asserted-by":"publisher","first-page":"34677","DOI":"10.1074\/jbc.M110.164350","volume":"285","author":"SH Schirmer","year":"2010","unstructured":"Schirmer SH, Bot PT, Fledderus JO, van der Laan AM, Volger OL, Laufs U, et al. Blocking interferon beta stimulates vascular smooth muscle cell proliferation and arteriogenesis. J Biol Chem. 2010;285:34677\u201385. doi: 10.1074\/jbc.M110.164350 .","journal-title":"J Biol Chem"},{"key":"498_CR58","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3892\/ijo.2014.2620","volume":"45","author":"S Takano","year":"2014","unstructured":"Takano S, Ishikawa E, Matsuda M, Yamamoto T, Matsumura A. Interferon-beta inhibits glioma angiogenesis through downregulation of vascular endothelial growth factor and upregulation of interferon inducible protein 10. Int J Oncol. 2014;45:1837\u201346. doi: 10.3892\/ijo.2014.2620 .","journal-title":"Int J Oncol"},{"key":"498_CR59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4939-0320-7_6","volume":"1135","author":"CP Tsipis","year":"2014","unstructured":"Tsipis CP, Sun X, Xu K, Lamanna JC. Hypoxia-induced angiogenesis and capillary density determination. Methods Mol Biol. 2014;1135:69\u201380. doi: 10.1007\/978-1-4939-0320-7_6 .","journal-title":"Methods Mol Biol"},{"key":"498_CR60","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2337\/diab.46.5.887","volume":"46","author":"M Yoshioka","year":"1997","unstructured":"Yoshioka M, Kayo T, Ikeda T, Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL\/6 (Akita) mutant mice. Diabetes. 1997;46:887\u201394. doi: 10.2337\/diab.46.5.887 .","journal-title":"Diabetes"},{"key":"498_CR61","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2014.01.011","volume":"1552","author":"S Sonobe","year":"2014","unstructured":"Sonobe S, Fujimura M, Niizuma K, Nishijima Y, Ito A, Shimizu H, et al. Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: a susceptibility gene for moyamoya disease. Brain Res. 2014;1552:64\u201371. doi: 10.1016\/j.brainres.2014.01.011 .","journal-title":"Brain Res"},{"key":"498_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke. 2014;16:65\u201372. doi: 10.5853\/jos.2014.16.2.65 .","journal-title":"J Stroke"},{"key":"498_CR63","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.4049\/jimmunol.1403157","volume":"194","author":"PR Kasher","year":"2015","unstructured":"Kasher PR, Jenkinson EM, Briolat V, Gent D, Morrissey C, Zeef LA, et al. Characterization of samhd1 morphant zebrafish recapitulates features of the human type I interferonopathy Aicardi\u2013Goutieres syndrome. J Immunol. 2015;194:2819\u201325.","journal-title":"J Immunol"},{"key":"498_CR64","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1038\/emboj.2013.163","volume":"32","author":"J Rehwinkel","year":"2013","unstructured":"Rehwinkel J, Maelfait J, Bridgeman A, Rigby R, Hayward B, Liberatore RA, et al. SAMHD1-dependent retroviral control and escape in mice. EMBO J. 2013;32:2454\u201362.","journal-title":"EMBO J"},{"key":"498_CR65","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","volume":"15","author":"YJ Crow","year":"2015","unstructured":"Crow YJ, Manel N. Aicardi\u2013Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15:429\u201340. doi: 10.1038\/nri3850 .","journal-title":"Nat Rev Immunol"},{"key":"498_CR66","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s00234-003-0990-4","volume":"45","author":"Aquino Gondim Fde","year":"2003","unstructured":"Aquino Gondim Fde. A, Leacock RO, Subrammanian TA, Cruz-Flores S. Intracerebral hemorrhage associated with Sneddon\u2019s syndrome: is ischemia-related angiogenesis the cause? Case report and review of the literature. Neuroradiology. 2003;45:368\u201372. doi: 10.1007\/s00234-003-0990-4 .","journal-title":"Neuroradiology"},{"key":"498_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1052-3057(99)80054-8","volume":"8","author":"JR Carhuapoma","year":"1999","unstructured":"Carhuapoma JR, D\u2019Olhaberriague L, Levine SR. Moyamoya syndrome associated with Sneddon\u2019s syndrome and antiphospholipid-protein antibodies. J Stroke Cerebrovasc Dis. 1999;8:51\u20136. doi: 10.1016\/S1052-3057(99)80054-8 .","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"498_CR68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.clineuro.2014.12.001","volume":"129","author":"F Fierini","year":"2015","unstructured":"Fierini F, Barilaro A, Giambene B, Carlucci G, Grandi V, Maio V, et al. Moyamoya in a patient with Sneddon\u2019s syndrome. Clin Neurol Neurosurg. 2015;129:34\u20136. doi: 10.1016\/j.clineuro.2014.12.001 .","journal-title":"Clin Neurol Neurosurg"},{"key":"498_CR69","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Stone DL, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370:911\u201320. doi: 10.1056\/NEJMoa1307361 .","journal-title":"N Engl J Med"},{"key":"498_CR70","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ajhg.2009.04.007","volume":"84","author":"DC Guo","year":"2009","unstructured":"Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617\u201327. doi: 10.1016\/j.ajhg.2009.04.007 .","journal-title":"Am J Hum Genet"},{"key":"498_CR71","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajhg.2014.01.018","volume":"94","author":"D Herve","year":"2014","unstructured":"Herve D, Philippi A, Belbouab R, Zerah M, Chabrier S, Collardeau-Frachon S, et al. Loss of alpha1beta1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia. Am J Hum Genet. 2014;94:385\u201394. doi: 10.1016\/j.ajhg.2014.01.018 .","journal-title":"Am J Hum Genet"},{"key":"498_CR72","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrd4252","volume":"13","author":"ER Andersson","year":"2014","unstructured":"Andersson ER, Lendahl U. Therapeutic modulation of Notch signalling\u2013are we there yet? Nat Rev Drug Discov. 2014;13:357\u201378. doi: 10.1038\/nrd4252 .","journal-title":"Nat Rev Drug Discov"},{"key":"498_CR73","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/01.STR.9.1.45","volume":"9","author":"KH Merkel","year":"1978","unstructured":"Merkel KH, Ginsberg PL, Parker JC Jr, Post MJ. Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation. Stroke. 1978;9:45\u201352. doi: 10.1161\/01.STR.9.1.45 .","journal-title":"Stroke"},{"key":"498_CR74","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00467-008-0847-5","volume":"23","author":"HW Park","year":"2008","unstructured":"Park HW, Oh D, Kim N, Cho HY, Moon KC, Chae JH, et al. Congenital thrombotic thrombocytopenic purpura associated with unilateral moyamoya disease. Pediatr Nephrol. 2008;23:1555\u20138. doi: 10.1007\/s00467-008-0847-5 .","journal-title":"Pediatr Nephrol"},{"key":"498_CR75","first-page":"573","volume":"23","author":"M Salih","year":"1995","unstructured":"Salih M, Andeejani A, Gader A, Kolawole T, Palkar V. Moyamoya syndrome associated with protein C deficiency. Med Sci Res. 1995;23:573\u20135.","journal-title":"Med Sci Res"},{"key":"498_CR76","first-page":"567","volume":"22","author":"H Hiyama","year":"1994","unstructured":"Hiyama H, Kusano R, Muragaki Y, Miura N. Moyamoya disease associated with thrombotic thrombocytopenic purpura (TTP). No Shinkei Geka. 1994;22:567\u201372.","journal-title":"No Shinkei Geka"},{"key":"498_CR77","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1542\/peds.2013-3251","volume":"133","author":"A Artoni","year":"2014","unstructured":"Artoni A, Selicorni A, Passamonti SM, Lecchi A, Bucciarelli P, Cerutti M, et al. Hemostatic abnormalities in Noonan syndrome. Pediatrics. 2014;133:e1299\u2013304. doi: 10.1542\/peds.2013-3251 .","journal-title":"Pediatrics"},{"key":"498_CR78","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1161\/ATVBAHA.114.304249","volume":"34","author":"BE Tourdot","year":"2014","unstructured":"Tourdot BE, Conaway S, Niisuke K, Edelstein LC, Bray PF, Holinstat M. Mechanism of race-dependent platelet activation through the protease-activated receptor-4 and Gq signaling axis. Arterioscler Thromb Vasc Biol. 2014;34:2644\u201350. doi: 10.1161\/ATVBAHA.114.304249 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"498_CR79","doi-asserted-by":"publisher","first-page":"e001000","DOI":"10.1161\/JAHA.114.001000","volume":"3","author":"S Lattanzio","year":"2014","unstructured":"Lattanzio S, Santilli F, Liani R, Vazzana N, Ueland T, Di Fulvio P, et al. Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. J Am Heart Assoc. 2014;3:e001000. doi: 10.1161\/JAHA.114.001000 .","journal-title":"J Am Heart Assoc"},{"key":"498_CR80","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI41443","volume":"120","author":"EA Lasater","year":"2010","unstructured":"Lasater EA, Li F, Bessler WK, Estes ML, Vemula S, Hingtgen CM, et al. Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans. J Clin Invest. 2010;120:859\u201370. doi: 10.1172\/JCI41443 .","journal-title":"J Clin Invest"},{"key":"498_CR81","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/hmg\/ddn134","volume":"17","author":"EA Lasater","year":"2008","unstructured":"Lasater EA, Bessler WK, Mead LE, Horn WE, Clapp DW, Conway SJ, et al. Nf1+\/\u2212 mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway. Hum Mol Genet. 2008;17:2336\u201344. doi: 10.1093\/hmg\/ddn134 .","journal-title":"Hum Mol Genet"},{"key":"498_CR82","doi-asserted-by":"publisher","first-page":"L912","DOI":"10.1152\/ajplung.00014.2012","volume":"303","author":"J Zhang","year":"2012","unstructured":"Zhang J, Hu H, Palma NL, Harrison JK, Mubarak KK, Carrie RD, et al. Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion. Am J Physiol Lung Cell Mol Physiol. 2012;303:L912\u201322. doi: 10.1152\/ajplung.00014.2012 .","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"498_CR83","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/bjs.1800810904","volume":"81","author":"MG Davies","year":"1994","unstructured":"Davies MG, Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg. 1994;81:1254\u201369.","journal-title":"Br J Surg"},{"key":"498_CR84","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.114.302221","volume":"114","author":"PM George","year":"2014","unstructured":"George PM, Oliver E, Dorfmuller P, Dubois OD, Reed DM, Kirkby NS, et al. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circ Res. 2014;114:677\u201388. doi: 10.1161\/CIRCRESAHA.114.302221 .","journal-title":"Circ Res"},{"key":"498_CR85","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.bbadis.2015.04.011","volume":"1852","author":"ML Buckley","year":"2015","unstructured":"Buckley ML, Ramji DP. The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis. Biochim Biophys Acta. 2015;1852:1498\u2013510. doi: 10.1016\/j.bbadis.2015.04.011 .","journal-title":"Biochim Biophys Acta"},{"key":"498_CR86","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1038\/ncomms6160","volume":"5","author":"SM Zhang","year":"2014","unstructured":"Zhang SM, Zhu LH, Chen HZ, Zhang R, Zhang P, Jiang DS, et al. Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nat Commun. 2014;5:5160. doi: 10.1038\/ncomms6160 .","journal-title":"Nat Commun"},{"key":"498_CR87","doi-asserted-by":"publisher","unstructured":"Chong PF, Ogata R, Kobayashi H, Koizumi A, Kira R. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K. Brain Dev (online:2014.12.26), doi: 10.1016\/j.braindev.2014.12.006 .","DOI":"10.1016\/j.braindev.2014.12.006"},{"key":"498_CR88","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ajhg.2011.04.017","volume":"88","author":"S Miskinyte","year":"2011","unstructured":"Miskinyte S, Butler MG, Herve D, Sarret C, Nicolino M, Petralia JD, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet. 2011;88:718\u201328. doi: 10.1016\/j.ajhg.2011.04.017 .","journal-title":"Am J Hum Genet"},{"key":"498_CR89","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1253\/jcj.62.136","volume":"62","author":"T Akasaki","year":"1998","unstructured":"Akasaki T, Kagiyama S, Omae T, Ohya Y, Ibayashi S, Abe I, et al. Asymptomatic moyamoya disease associated with coronary and renal artery stenoses\u2014a case report. Jpn Circ J. 1998;62:136\u20138. doi: 10.1253\/jcj.62.136 .","journal-title":"Jpn Circ J"},{"key":"498_CR90","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1161\/CIRCULATIONAHA.112.136473","volume":"127","author":"JH Lee","year":"2013","unstructured":"Lee JH, Youn TJ, Yoon YE, Park JJ, Hong SJ, Chun EJ, et al. Coronary artery stenosis in moyamoya disease: tissue characterization by 256-slice multi-detector CT and virtual histology. Circulation. 2013;127:2063\u20135. doi: 10.1161\/CIRCULATIONAHA.112.136473 .","journal-title":"Circulation"},{"key":"498_CR91","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13256-015-0537-4","volume":"9","author":"W Choi","year":"2015","unstructured":"Choi W, Kim YN, Kim KH. Variant angina in moyamoya disease\u2014a correlative etiology and different presentation: a case report. J Med Case Rep. 2015;9:86. doi: 10.1186\/s13256-015-0537-4 .","journal-title":"J Med Case Rep"},{"key":"498_CR92","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3346\/jkms.2015.30.4.470","volume":"30","author":"TM Nam","year":"2015","unstructured":"Nam TM, Jo KI, Yeon JY, Hong SC, Kim JS. Coronary heart disease in moyamoya disease: are they concomitant or coincidence? J Korean Med Sci. 2015;30:470\u20134. doi: 10.3346\/jkms.2015.30.4.470 .","journal-title":"J Korean Med Sci"},{"key":"498_CR93","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1161\/01.STR.22.11.1358","volume":"22","author":"E Ikeda","year":"1991","unstructured":"Ikeda E. Systemic vascular changes in spontaneous occlusion of the circle of Willis. Stroke. 1991;22:1358\u201362. doi: 10.1161\/01.STR.22.11.1358 .","journal-title":"Stroke"},{"key":"498_CR94","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1161\/01.STR.31.3.733","volume":"31","author":"I Yamada","year":"2000","unstructured":"Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with moyamoya disease: angiographic findings. Stroke. 2000;31:733\u20137. doi: 10.1161\/01.STR.31.3.733 .","journal-title":"Stroke"},{"key":"498_CR95","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2214\/ajr.183.1.1830119","volume":"183","author":"O Togao","year":"2004","unstructured":"Togao O, Mihara F, Yoshiura T, Tanaka A, Kuwabara Y, Morioka T, et al. Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol. 2004;183:119\u201322. doi: 10.2214\/ajr.183.1.1830119 .","journal-title":"AJR Am J Roentgenol"},{"key":"498_CR96","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00701-012-1472-4","volume":"154","author":"Y Kaku","year":"2012","unstructured":"Kaku Y, Morioka M, Ohmori Y, Kawano T, Kai Y, Fukuoka H, et al. Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir. 2012;154:2151\u20137. doi: 10.1007\/s00701-012-1472-4 .","journal-title":"Acta Neurochir"},{"key":"498_CR97","first-page":"37","volume":"9","author":"K Takeuchi","year":"1957","unstructured":"Takeuchi K, Shimizu K. Hypoplasia of the bilateral internal carotid arteries. No Shinkei. 1957;9:37\u201343 (in Japanese).","journal-title":"No Shinkei"},{"key":"498_CR98","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1034\/j.1399-0004.2000.580501.x","volume":"58","author":"SJ Hamilton","year":"2000","unstructured":"Hamilton SJ, Friedman JM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet. 2000;58:341\u20134. doi: 10.1034\/j.1399-0004.2000.580501.x .","journal-title":"Clin Genet"},{"key":"498_CR99","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000064398","volume":"37","author":"JP Farmer","year":"2002","unstructured":"Farmer JP, Khan S, Khan A, Ortenberg J, Freeman C, O\u2019Gorman AM, et al. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review. Pediatr Neurosurg. 2002;37:122\u201336.","journal-title":"Pediatr Neurosurg"},{"key":"498_CR100","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1212\/01.WNL.0000150544.00016.69","volume":"64","author":"TL Rosser","year":"2005","unstructured":"Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. Neurology. 2005;64:553\u20135. doi: 10.1212\/01.WNL.0000150544.00016.69 .","journal-title":"Neurology"},{"key":"498_CR101","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3171\/2012.12.PEDS12281","volume":"11","author":"M Koss","year":"2013","unstructured":"Koss M, Scott RM, Irons MB, Smith ER, Ullrich NJ. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr. 2013;11:417\u201325. doi: 10.3171\/2012.12.PEDS12281 .","journal-title":"J Neurosurg Pediatr"},{"key":"498_CR102","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0887-8994(97)89980-8","volume":"16","author":"V Ganesan","year":"1997","unstructured":"Ganesan V, Kirkham FJ. Noonan syndrome and moyamoya. Pediatr Neurol. 1997;16:256\u20138. doi: 10.1016\/S0887-8994(97)89980-8 .","journal-title":"Pediatr Neurol"},{"key":"498_CR103","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.pediatrneurol.2004.05.015","volume":"31","author":"Y Yamashita","year":"2004","unstructured":"Yamashita Y, Kusaga A, Koga Y, Nagamitsu S, Matsuishi T. Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndrome. Pediatr Neurol. 2004;31:364\u20136. doi: 10.1016\/j.pediatrneurol.2004.05.015 .","journal-title":"Pediatr Neurol"},{"key":"498_CR104","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.pediatrneurol.2004.12.010","volume":"32","author":"T Shiihara","year":"2005","unstructured":"Shiihara T, Kato M, Mitsuhashi Y, Hayasaka K. Costello syndrome showing moyamoya-like vasculopathy. Pediatr Neurol. 2005;32:361\u20133. doi: 10.1016\/j.pediatrneurol.2004.12.010 .","journal-title":"Pediatr Neurol"},{"key":"498_CR105","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.pediatrneurol.2014.11.017","volume":"52","author":"JH Choi","year":"2015","unstructured":"Choi JH, Oh MY, Yum MS, Lee BH, Kim GH, Yoo HW. Moyamoya syndrome in a patient with Noonan-like syndrome with loose anagen hair. Pediatr Neurol. 2015;52:352\u20135. doi: 10.1016\/j.pediatrneurol.2014.11.017 .","journal-title":"Pediatr Neurol"},{"key":"498_CR106","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ajmg.1320330112","volume":"33","author":"A Rachmel","year":"1989","unstructured":"Rachmel A, Zeharia A, Neuman-Levin M, Weitz R, Shamir R, Dinari G. Alagille syndrome associated with moyamoya disease. Am J Med Genet. 1989;33:89\u201391. doi: 10.1002\/ajmg.1320330112 .","journal-title":"Am J Med Genet"},{"key":"498_CR107","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1161\/01.CIR.0000121361.01862.A4","volume":"109","author":"BM Kamath","year":"2004","unstructured":"Kamath BM, Spinner NB, Emerick KM, Chudley AE, Booth C, Piccoli DA, et al. Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation. 2004;109:1354\u20138. doi: 10.1161\/01.CIR.0000121361.01862.A4 .","journal-title":"Circulation"},{"key":"498_CR108","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1440-1673.2006.01668.x","volume":"51","author":"A Al Kaissi","year":"2007","unstructured":"Al Kaissi A, Bieganski T, Baranska D, Chehida FB, Gharbi H, Ghachem MB, et al. Robinow syndrome: report of two cases and review of the literature. Australas Radiol. 2007;51:83\u20136. doi: 10.1111\/j.1440-1673.2006.01668.x .","journal-title":"Australas Radiol"},{"key":"498_CR109","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000204907","volume":"45","author":"R Qaiser","year":"2009","unstructured":"Qaiser R, Scott RM, Smith ER. Identification of an association between Robinow syndrome and moyamoya. Pediatr Neurosurg. 2009;45:69\u201372. doi: 10.1159\/000204907 .","journal-title":"Pediatr Neurosurg"},{"key":"498_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s004310050001","volume":"159","author":"CF Boerkoel","year":"2000","unstructured":"Boerkoel CF, O\u2019Neill S, Andre JL, Benke PJ, Bogdanovic R, Bulla M, et al. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr. 2000;159:1\u20137.","journal-title":"Eur J Pediatr"},{"key":"498_CR111","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/ajmg.a.31878","volume":"143A","author":"T Lucke","year":"2007","unstructured":"Lucke T, Clewing JM, Boerkoel CF, Hartmann H, Das AM, Knauth M, et al. Cerebellar atrophy in Schimke-immuno-osseous dysplasia. Am J Med Genet A. 2007;143A:2040\u20135. doi: 10.1002\/ajmg.a.31878 .","journal-title":"Am J Med Genet A"},{"key":"498_CR112","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1151174","volume":"319","author":"A Rauch","year":"2008","unstructured":"Rauch A, Thiel CT, Schindler D, Wick U, Crow YJ, Ekici AB, et al. Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science. 2008;319:816\u20139. doi: 10.1126\/science.1151174 .","journal-title":"Science"},{"key":"498_CR113","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/ajmg.a.33252","volume":"152A","author":"MB Bober","year":"2010","unstructured":"Bober MB, Khan N, Kaplan J, Lewis K, Feinstein JA, Scott CI Jr, et al. Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype. Am J Med Genet A. 2010;152A:960\u20135. doi: 10.1002\/ajmg.a.33252 .","journal-title":"Am J Med Genet A"},{"key":"498_CR114","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3171\/2008.12.PEDS08205","volume":"3","author":"PJ Codd","year":"2009","unstructured":"Codd PJ, Scott RM, Smith ER. Seckel syndrome and moyamoya. J Neurosurg Pediatr. 2009;3:320\u20134. doi: 10.3171\/2008.12.PEDS08205 .","journal-title":"J Neurosurg Pediatr"},{"key":"498_CR115","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0887-8994(97)00072-6","volume":"17","author":"A Charuvanij","year":"1997","unstructured":"Charuvanij A, Laothamatas J, Torcharus K, Sirivimonmas S. Moyamoya disease and protein S deficiency: a case report. Pediatr Neurol. 1997;17:171\u20133. doi: 10.1016\/S0887-8994(97)00072-6 .","journal-title":"Pediatr Neurol"},{"key":"498_CR116","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/01.STR.32.8.1786","volume":"32","author":"M Bonduel","year":"2001","unstructured":"Bonduel M, Hepner M, Sciuccati G, Torres AF, Tenembaum S. Prothrombotic disorders in children with moyamoya syndrome. Stroke. 2001;32:1786\u201392. doi: 10.1161\/01.STR.32.8.1786 .","journal-title":"Stroke"},{"key":"498_CR117","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","volume":"63","author":"GA Martin","year":"1990","unstructured":"Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990;63:843\u20139.","journal-title":"Cell"},{"key":"498_CR118","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","volume":"63","author":"GF Xu","year":"1990","unstructured":"Xu GF, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell. 1990;63:835\u201341.","journal-title":"Cell"},{"key":"498_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.37259","author":"YA Addissie","year":"2015","unstructured":"Addissie YA, Kotecha U, Hart RA, Martinez AF, Kruszka P, Muenke M. Craniosynostosis and Noonan syndrome with KRAS mutations: expanding the phenotype with a case report and review of the literature. Am J Med Genet A. 2015;. doi: 10.1002\/ajmg.a.37259 .","journal-title":"Am J Med Genet A"},{"key":"498_CR120","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/ng1641","volume":"37","author":"Y Aoki","year":"2005","unstructured":"Aoki Y, Niihori T, Kawame H, Kurosawa K, Ohashi H, Tanaka Y, et al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat Genet. 2005;37:1038\u201340. doi: 10.1038\/ng1641 .","journal-title":"Nat Genet"},{"key":"498_CR121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dvdy.21991","volume":"239","author":"Y Minami","year":"2010","unstructured":"Minami Y, Oishi I, Endo M, Nishita M. Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev Dyn. 2010;239:1\u201315.","journal-title":"Dev Dyn"},{"key":"498_CR122","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/ng821","volume":"30","author":"CF Boerkoel","year":"2002","unstructured":"Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet. 2002;30:215\u201320.","journal-title":"Nat Genet"},{"key":"498_CR123","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.158","author":"G Yigit","year":"2015","unstructured":"Yigit G, Brown KE, Kayserili H, Pohl E, Caliebe A, Zahnleiter D, et al. Mutations in CDK5RAP2 cause Seckel syndrome. Mol Genet Genom Med. 2015;. doi: 10.1002\/mgg3.158 .","journal-title":"Mol Genet Genom Med"},{"key":"498_CR124","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13023-014-0215-4","volume":"9","author":"S Wu","year":"2014","unstructured":"Wu S, Xu Z, Liang H. Sneddon\u2019s syndrome: a comprehensive review of the literature. Orphanet J Rare Dis. 2014;9:215\u201321.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Environmental Health and Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12199-015-0498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12199-015-0498-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12199-015-0498-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12199-015-0498-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T01:01:24Z","timestamp":1718240484000},"score":1,"resource":{"primary":{"URL":"http:\/\/environhealthprevmed.biomedcentral.com\/articles\/10.1007\/s12199-015-0498-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,10]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["498"],"URL":"https:\/\/doi.org\/10.1007\/s12199-015-0498-7","relation":{},"ISSN":["1342-078X","1347-4715"],"issn-type":[{"value":"1342-078X","type":"print"},{"value":"1347-4715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,10]]}}}